1. Introduction
Teeth possess multiple functions. Besides mastication, they are important for taste, tactile sense, speech and esthetics. The longevity of teeth is critical for the maintenance and enhancement of quality of life. Over fifty percent of extracted teeth are caused by caries and root fracture. Deep caries and pulp exposure have been treated by pulp capping or partial pulp amputation to preserve pulp tissue, with limited success. In case of irreversible pulpitis,the entire pulp has to be removed and the root canal space has to be completely filled with artificial materials after disinfection. However, incomplete disinfection and coronal leakage cause periapical disease. The endodontic success rate is less than 50-70% for retreatment of those endodontically failed teeth with periapical lesions and/or some clinical symptoms. Enlargement and debridement of infected root canals render teeth brittle. The post-operative procedures with post preparation also increase the possibility of root fracture. Therefore, loss of pulp vitality is highly associated with root fracture and tooth loss. There has been no superior synthetic material to replace natural pulp and dentin. Thus, regenerating pulp-dentin tissues seems to be an ideal approach to restore tooth functions compromised by pulp injury and/or inflammation (Nakashima and Akamine, 2005; Nakashima, et al., 2009). Under natural conditions, pulp and dentin have limited capacity to regenerate and repair when damaged. This chapter describes recent advances and promising approaches for pulp regeneration, including isolation and characteristics of pulp stem/progenitor cells and partial and complete regeneration of pulp. The complete pulp regeneration with other tissue stem cells is also addressed.
2. Pulp regeneration in mature teeth with complete apical closure
2.1. Pulp stem/progenitor cells suitable for pulp regeneration
Dental pulp tissue is rich in vasculature and innervation. There is an intimate association of innervation with vasculature of the dental pulp, involving in pulp homeostasis. Thus, angiogenesis and re-innervation are critical prerequisites for pulp regeneration (Nakashima and Akamine, 2005). Numerous studies have reported the isolation of adult pulp stem/progenitor cells with high proliferative and multi-differentiation potential in vitro. However, only a few studies have demonstrated angiogenesis and re-innervation in vivo after transplantation.
Porcine and human pulp CD31-side population(SP) cells and CD105/endoglin+cells, positive for CD29, CD44, CD73, and Thy-1/CD90, and negative for CD31, CD45 and CD133, increase the blood flow including high density of capillary formation after transplantation into mouse hindlimb ischemia (Iohara et al., 2008; Nakashima et al., 2009). SP cells are enriched in the ‘true’ or ‘mother’ adult stem cells, which exhibite lower level of the DNA binding fluorescent dye, Hoechst 33342than the rest of pulp cells. CD105/endoglin is a component of the transforming growth factor-beta receptor complex. CD105 is widely expressed on mesenchymal stem cells (MSCs), and the positive isolation strategy based on the selection of the cells that express CD105 has been proposed for isolation of MSCs. Pulp CD31-cells and CD105+cells induce angiogenesis and neurogenesis in rat cerebral ischemia by releasing neurotrophic factors, such as VEGF in peri-infarct area and promoting migration and differentiation of the endogenous neuronal progenitor cells, and accelerate the functional recovery (Sugiyama, et al., 2011). Local transplantation of these pulp stem/progenitor cells results in successful engraftment in proximity to the newly formed vasculature without direct incorporation into vessels, suggesting enhancement of angiogenesis and re-innervation by trophic effects (Iohara, 2008; Sugiyama, 2011). The conditioned medium of pulp stem/progenitor cells contain high concentration of angiogenic/neurotrophic factors such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), vascular endothelial growth factor (VEGF-A), glial cell-line derived neurotrophic factor (GDNF), granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), matrix metalloproteinase 3 (MMP3). These factors have effect on proliferation, migration, and anti-apoptosis (Iohara, 2008, Sugiyama, 2011). On the other hand, unfractionated total pulp cells express lower level of angiogenic/neurotrophic factors, and are less effective on angiogenesis and neurogenesis compared to CD31-SP cells and CD105+cells after transplantation in hindlimb ischemia and brain ischemia (Nakashima, et al., 2009). Thus, potential utility of some subfractions of pulp stem/progenitor cells has been demonstrated as cell sources for cell-based therapy of angiogenesis, re-innervation and pulp regeneration. MSCs secrete soluble cytokines and growth factors that function in a paracrine fashion, contributing to repair and regeneration by enhanced cell survival, angiogenesis, neurogenesis and neuroprotection, and by activating endogenous stem cells (Kassis et al., 2011).
2.2. Partial pulp regeneration with pulp stem/progenitor cells
Recent advances in tissue regeneration have led to the possibility of partial pulp regeneration in case of pulp exposure or pulpotomy of partial pulptitis. There are two methods in partial pulp regeneration even in mature teeth with complete apical closure; (i)transplantation of pulp stem/progenitor cells with scaffold or engineered pulp tissue, and (ii) application of migration/homing factors with scaffolds.
The first method (Figure 1A) is evidenced by an experiment in which canine autologous pulp CD31-SP cells are transplanted in the cavity on the amputated pulp one day after three dimensional cultures with collagen scaffold. The cavity on the amputated pulp is filled with the pulp tissue with well-developed vasculature and innervations (Figure 2A, C-E). The tubular dentin is formed along the dentinal wall (Figure 2F, G) (Iohara, et al., 2009). Many of transplanted CD31-SP cells are in the proximity of the newly formed capillaries and express angiogenic/neurotrophic factors, implicating trophic effects on neovascularization (Iohara et al., 2009). On the other hand, after transplantation of CD31+SP cells, fewer capillaries and lower volume of the regenerated tissue are seen in the cavity on the amputated pulp compared with transplantation of CD31-SP cells (Figure 2C)(Iohara, et al., 2009), suggesting different potential utility in induction of pulp regeneration among subfractions of pulp stem/progenitor cells.
2.3. Complete pulp regeneration with pulp stem/progenitor cells and migration factors
Complete pulp regeneration is optimistically considered by transplantation of autologous pulp stem/progenitor cells in case of irreversible pulpitis of even mature teeth with complete apical closure. The transplanted cells should survive with nutrition and oxygen in the pulpectomized root canals before revascularization. Some subfractions of pulp stem/progenitor cells, such as CD105+cells or CD31-SP cells, have more regenerative potential compared with unfractionated total pulp cells. Pulp stem/progenitor cells are capable to induce angiogenesis and re-innervation without direct incorporation into vasculature. Thus, the induction of MSC recruitment from surrounding tissues or from the circulation by migration/homing factors together with transplanted stem/progenitor cells can be a helpful modality to initiate and support cell therapy for pulp regeneration. Pulp CD31-SP cells and CD105+cells are CXCR4-positive, having high migratory and proliferative activities with SDF-1 (Iohara, et al., 2008; Nakashima, et al., 2009). Thus, one candidate for migration/homing factors is SDF-1, a chemokine for CXCR4-positive stem cells. It is plausible that SDF-1 transplanted with pulp stem cells provides signals for homing and proliferation of endogenous stem cells originating from surrounding periodontal ligament, bone marrow and vasculature.
Optimal scaffolds should also be developed for efficient and safe complete pulp regeneration. It is critical for the scaffold to be injected into the root canal with optimal flow, devoid of bubble formation and mechanical properties after hardening in vivo. In addition the scaffold has to be biocompatible, with high bioactivity to integrate trophic factors secreted by stem cells. Furthermore it should be biodegradable by releasing these factors to replace the damaged tissue by newly regenerated tissue without immune response. In addition, the scaffold should not stimulate mineralization and differentiation of odontoblasts and/or osteodentinoblasts in the root canal except along the dentinal wall for pulp regeneration (Nakashima, et al., 2009). Potential scaffolds include natural polymers, such as collagen and gelatin with good biocompatibility and bioactivity (Nakashima and Akamine, 2005).
Thus, based on the concepts described above, pulp regeneration has been demonstrated by using the triad, stem/progenitor cells, migration/homing factors and optimal scaffolds (Nakashima, et al., 2011, Iohara, et al., 2011)(Figure 1B). Pulpectomy with enlarged apical portion, 0.6~0.7 mm in width, was performed in mature teeth with complete apical closure in an experimental model in dogs (Iohara, et al., 2011, Ishizaka et al., 2012). Current evidence shows that the root canal is filled with pulp-like loose connective tissue with vasculature and nerves after autologous transplantation of pulp stem/progenitor cells, CD31-SP cells or pulp CD105+cells, 5
2.4. Other sources of tissue stem cells for pulp regeneration
Supply of autologous pulp tissue declines with age, and alternative sources of MSCs to pulp stem cells are necessary for clinical application in endodontic treatment. Some transcriptional and epigenetic analyses have revealed very similar profiles among a variety of MSCs from bone marrow, adipose tissue, placenta, umbilical cord and amnion (Aranda etal., 2009; Boeuf and Richter, 2010). Different expression profile of trophic factors and growth factors, however, has also been reported among MSC populations (Noël et al., 2008; Boeuf and Richter, 2010; Philippe et al., 2010). Thus, it is necessary to investigate the requirements and preconditions of MSCs for effective induction of pulp regeneration (Ishizaka, et al., 2012). A candidate of an alternative cell source for pulp regeneration is autologous bone marrow and adipose tissue-derived MSCs due to neither ethical nor immunoreactive considerations. Transplantation of adipose CD31-SP cells resulted in formation of a similar amount of regenerated tissue compared with that of pulp CD31-SP cells (Figure 4A, C). Bone marrow CD31-SP cell transplantation induce significantly less amount of regenerated tissue compared with other two (Figure 4B, D). Those regenerated tissues, however, are all identical to pulp tissue confirmed by morphological and functional similarity, mRNA expression patterns of microarray analyses and two-dimensional electrophoretic analyses (Ishizaka, 2012). Thus, it is suggested that MSCs from different sources are comparable in pulp regeneration in vivo and that their capabilities are not influenced by the niche of their origin. Enhanced matrix formation in adipose cell transplantation, which lead to root canal obliteration after longer period, suggest that some trophic factors, growth/differentiation factors and/or inhibitors of stemness may influence on active pathway for differentiation in adipose stem cells. Further studies are needed to elucidate its involved pathways and processes.
3. Conclusion
Cell therapy with subfractions of pulp stem/progenitor cells, CD31-SP cells or pulp CD105+ cells is capable to induce pulp regeneration, presenting the following features: i) vascularization, ii) similar cell density and architecture of the extracellular matrix as the natural pulp, iii) new odontoblasts aligning with the dentinal wall to produce new dentin, and iv) innervation.
CD31-SP cells have to be labeled with DNA binding Hoechst 33342 and isolated by flowcytometry, which requires the confirmation of safety. CD105+cells have to be isolated by magnetic antibody beads method if not by flowcytometry, and have to be cost effective. The unfractionated total pulp cells by colony formation method are less suitable for pulp regeneration since the regenerated tissue is much less in volume and much more to undergo mineralized compared with fractionated stem/progenitor cells. A novel isolation method capable of confirmation of safety and efficiency from a small amount of pulp tissue should be developed prior to clinical trials. Although there are still some hurdles to overcome in regenerative endodontics, there are the rewards of immense clinical advantages and benefits for patients to maintain the function and longevity of teeth resulting in maintenance of whole body and enhancement of quality of life.
Acknowledgments
This work was supported by Collaborative Development of Innovative Seeds, Potentiality Verification Stage from Japan Science and Technology Agency to MN; and the Research Grant for Longevity Sciences (21A-7) from the Ministry of Health, Labour and Welfare to MN.
References
- 1.
Aranda P Agirre X Ballestar E Andreu E. J Román-gómez J Prieto I et al 2009 Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS One 4(11):e7809.Aranda, P.; Agirre, X.; Ballestar, E.; Andreu, E.J.; Román-Gómez, J. & Prieto, I. et al. (2009). Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS One 4(11):e7809. - 2.
Boeuf S Richter W 2010 Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors.Stem Cell Res Ther 1(4):31.Iohara, K.;Zheng, L.;Wake, H.;Ito, M.;Nabekura, J. &Wakita, H. et al. (2008). A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp.Stem Cells 26 9 2408 2418 Boeuf, S. & Richter, W. (2010). Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors. Stem Cell Res Ther 1(4):31. - 3.
Iohara, K.; Zheng, L.; Wake, H.; Ito, M.; Nabekura, J. & Wakita, H. et al. (2008). A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp. Stem Cells 26(9):2408-2418. - 4.
Iohara K Zheng L Ito M Ishizaka R Nakamura H Into T et al 2009 Regeneration of dental pulp after pulpotomy by transplantation of CD31-/CD146-side population cells from a canine tooth.Regen Med 4 3 377 385 Iohara, K.; Zheng, L.; Ito, M.; Ishizaka,R.; Nakamura, H. & Into T. et al. (2009). Regeneration of dental pulp after pulpotomy by transplantation of CD31-/CD146-side population cells from a canine tooth. Regen Med 4(3): 377-385. - 5.
Iohara K Imabayashi K Ishizaka R Watanabe A Nabekura J Ito M Matsushita K Nakamura H Nakashima M 2011 Complete pulp regeneration after pulpectomy by transplantation of CD105+stem cells with stromal cell-derived factor-1.Tissue Eng Part A 17(15-16): 1911-1920.Iohara, K.; Imabayashi, K.; Ishizaka, R.; Watanabe, A.; Nabekura, J.; Ito, M.; Matsushita, K.; Nakamura, H. & Nakashima, M. (2011). Complete pulp regeneration after pulpectomy by transplantation of CD105+ stem cells with stromal cell-derived factor-1. Tissue Eng Part A 17(15-16): 1911-1920. - 6.
Ishizaka R Iohara K Murakami M Fukuta O Nakashima M 2012 Regeneration of dental pulp following pulpectomy by fractionated stem/progenitor cells from bone marrow and adipose tissue.Biomaterials 33 7 2109 2118 Ishizaka, R.; Iohara, K.; Murakami, M.; Fukuta, O. &Nakashima, M. (2012). Regeneration of dental pulp following pulpectomy by fractionated stem/progenitor cells from bone marrow and adipose tissue. Biomaterials 33(7):2109-2118. - 7.
Nakashima M Akamine A 2005 The application of tissue engineering to regeneration of pulp and dentin in endodontics.J Endod 31 10 711 718 Nakashima, M. &Akamine, A. (2005). The application of tissue engineering to regeneration of pulp and dentin in endodontics. J Endod 31(10):711-718. - 8.
Kassis I Vaknin-dembinsky A Karussis D 2011 Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection.Curr Stem Cell Res Ther 6 1 63 68 Kassis, I.; Vaknin-Dembinsky, A. & Karussis, D. (2011). Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection. Curr Stem Cell Res Ther 6(1):63-68. - 9.
Nakashima M Iohara K Sugiyama M 2009 Human dental pulp stem cells with highly angiogenic and neurogenic potential for possible use in pulp regeneration.Cytokine & Growth Factor Reviews 20(5-6):435-440.Nakashima, M.; Iohara, K. & Sugiyama M (2009). Human dental pulp stem cells with highly angiogenic and neurogenic potential for possible use in pulp regeneration. Cytokine & Growth Factor Reviews 20(5-6):435-440. - 10.
Nakashima M Iohara K 2011 Regeneration of dental pulp by stem cells.Adv Dent Res 23 3 313 319 Nakashima, M. & Iohara, K. (2011). Regeneration of dental pulp by stem cells. Adv Dent Res 23(3): 313-319. - 11.
Noël D Caton D Roche S Bony C Lehmann S Casteilla L et al 2008 Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials.Exp Cell Res 314 7 1575 1584 Noël, D.; Caton, D.; Roche, S.; Bony, C.; Lehmann, S. & Casteilla L., et al. (2008). Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 314(7):1575-1584. - 12.
Philippe B Luc S Valérie P. B Jérôme R Alessandra B. R Louis C 2010 Culture and use of mesenchymal stromal cells in phase I and II clinical trials.Stem Cells Int 2010:503593.Philippe, B.; Luc, S.; Valérie, P.B.; Jérôme, R.; Alessandra, B.R. & Louis, C.(2010). Culture and use of mesenchymal stromal cells in phase I and II clinical trials. Stem Cells Int 2010:503593. - 13.
Sugiyama M Iohara K Wakita H Hattori H Ueda M Matsushita K Nakashima M 2011 Dental pulp-derived CD31(-)/CD146(-) side population stem/progenitor cells enhance recovery of focal cerebral ischemia in rats.Tissue Eng Part A 17(9-10):1303-1311.Sugiyama, M.; Iohara, K.; Wakita, H.; Hattori, H.; Ueda, M.; Matsushita, K. & Nakashima, M. (2011). Dental pulp-derived CD31(-)/CD146(-) side population stem/progenitor cells enhance recovery of focal cerebral ischemia in rats. Tissue Eng Part A 17(9-10):1303-1311.